title: Combining targeted therapeutics in the era of precision medicine.
authors.affiliation: 1] Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, UK [2] Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
authors.forename: D
authors.initials: D
authors.lastname: Papadatos-Pastos
authors.affiliation: 1] Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, UK [2] Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: De Miguel Luken
authors.affiliation: 1] Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, UK [2] Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
authors.forename: Timothy A
authors.initials: TA
authors.lastname: Yap
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*